Boston Scientific Corporation logo

Boston Scientific Corporation

BSX US

Boston Scientific CorporationUSUnited States Composite

66.67

USD
-0.33
(-0.49%)

Company Description

CEO
Mr. Michael F. Mahoney
Full Time Employees
48,000
Sector
Healthcare
Industry
Medical Devices
Address
300 Boston Scientific Way Marlborough MA United States 01752-1234
IPO Date
May 19, 1992
Business
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a Left Atrial Appendage Closure Device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

Company News

  • Here are Wall Street’s favorite stocks in the sector expected to grow profits the most in 2024

  • Here are Wall Street’s favorite stocks in the sector expected to grow profits the most in 2024

  • Axonics Shares Climb 20% After Acquisition by Boston Scientific

  • Axonics Stock Soars. It’s Being Acquired by Boston Scientific in $3.7 Billion Deal.

  • Boston Scientific to Acquire Axonics For About $3.7 Billion

  • Boston Scientific to Buy Axonics for $71 in Cash Per Share >BSX AXNX

  • Boston Scientific To Acquire Axonics For About $3.7 Bln

  • Axonics to Be Acquired by Boston Scientific for $71/Share Cash >BSX AXNX

  • 3 Medical-Device Stocks Could Click in 2024

  • Microsoft Tops the List of Best-Managed Companies of 2023

  • Boston Scientific, Edwards Lifesciences Tumble As Guidance 'Noise' Slams The Latter

  • Boston Scientific Gets Positive Results for Heart-Failure Device

  • Boston Scientific Stock Sees IBD RS Rating Improve To 74

  • 12 Roundtable Picks on the Future of Healthcare

  • 12 Picks to Play the Future of Healthcare, From Our Roundtable Pros

  • DraftKings Stock and 2 Other October Plays From J.P. Morgan

  • Stock Plays for October: 3 to Watch, According to J.P. Morgan

  • Boston Scientific Offers Bullish Guidance And Briefly Breaks Out

  • Health Care Roundup: Market Talk

  • 6 Growth Stocks That Look Recession-Resistant, According to Morgan Stanley